Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drospirenone: a novel progestin.

Andrea J Rapkin1, Sharon A Winer

  • 1Department of Obstetrics and Gynecology, David Geffen School of Medicine at UCLA, Los Angeles, CA 90095-1740, USA. arapkin@mednet.ucla.edu

Expert Opinion on Pharmacotherapy
|May 3, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prevalence of endometrial hyperplasia and carcinoma in women with polycystic ovarian syndrome.

F&S reports·2025
Same author

Letters to the Editor.

Menopause (New York, N.Y.)·2025
Same author

Comparison of estrogenic components used for hormonal contraception.

Contraception·2023
Same author

Symptom-associated alterations in functional connectivity in primary and secondary provoked vestibulodynia.

Pain·2022
Same author

Does timing matter when initiating elagolix in a natural menstrual cycle?

F&S reports·2021
Same author

Successful Vaginal Delivery after External Cephalic Version in a Woman with a Large Partial Uterine Septum.

Case reports in obstetrics and gynecology·2021
Same journal

Pharmacotherapeutic interventions for pediatric ulcerative colitis.

Expert opinion on pharmacotherapy·2026
Same journal

The rise and fall of TRPV1-targeted analgesia in osteoarthritis: a critical appraisal.

Expert opinion on pharmacotherapy·2026
Same journal

Dopamine transporter and beyond: evolving targets and combination strategies in stimulant use disorder.

Expert opinion on pharmacotherapy·2026
Same journal

GnRH antagonists for the treatment of fibroids and adenomyosis, current evidence and future perspectives.

Expert opinion on pharmacotherapy·2026
Same journal

Pharmacotherapeutic strategies for the management of congenital adrenal hyperplasia.

Expert opinion on pharmacotherapy·2026
Same journal

Current advances in pharmacotherapeutic strategies for the treatment of complicated intra-abdominal infections.

Expert opinion on pharmacotherapy·2026
See all related articles

Drospirenone, a progestin, offers benefits in oral contraceptives and menopausal therapy. It shows improved tolerability and can help manage premenstrual dysphoric disorder and postmenopausal symptoms.

Area of Science:

  • Endocrinology
  • Pharmacology
  • Women's Health

Background:

  • Drospirenone is a synthetic progestin with antimineralocorticoid and antiandrogenic properties.
  • It is used in combined oral contraceptives (COCs) and menopausal hormonal therapy (MHT).

Purpose of the Study:

  • To review the efficacy, safety, and tolerability of drospirenone-containing formulations.
  • To highlight the benefits of drospirenone in managing premenstrual dysphoric disorder (PMDD) and postmenopausal symptoms.

Main Methods:

  • Review of clinical studies and pharmacological data on drospirenone.
  • Analysis of efficacy and safety profiles in oral contraceptive and MHT regimens.

Main Results:

  • Drospirenone-containing COCs demonstrate comparable efficacy and safety to other low-dose COCs.

Related Experiment Videos

  • Improved tolerability noted for weight gain, mood changes, acne, and PMDD management.
  • In MHT, drospirenone with estradiol reduced vasomotor symptoms, maintained bone mass, aided weight management, and lowered blood pressure in postmenopausal women.

    • Conclusions:

    • Drospirenone is a versatile progestin with significant therapeutic applications in reproductive and postmenopausal health.
    • Its unique properties offer improved tolerability and specific benefits for various gynecological conditions.